$70
Semax is a synthetic ACTH-derived heptapeptide studied for its role in neurotrophic signaling, neurotransmitter regulation, neuroplasticity, and cognitive function. It is widely utilized in research involving central nervous system biology, learning processes, and neuronal communication pathways.
Independent analytical testing performed on supported batches.
Documentation linked to production and verification records.
Verification resources available for supported products and batches.
Synonym: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
CAS Number: 80714-61-0
Molecular Formula: C₃₇H₅₁N₉O₁₀
Molecular Weight: 813.86 g/mol
Structure: Synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10)
Semax is a synthetic heptapeptide developed from the biologically active region of adrenocorticotropic hormone (ACTH). Structural modifications were introduced to enhance stability and prolong biological activity while eliminating hormonal effects associated with the parent molecule.
The peptide is widely studied in research involving neurotransmitter regulation, neurotrophic signaling, cognitive processes, neuroplasticity, and central nervous system function.
Semax appears to influence multiple neurological signaling pathways:
The peptide functions through broad neuromodulatory activity rather than direct activation of a single receptor system.
Semax consists of the amino acid sequence:
Met-Glu-His-Phe-Pro-Gly-Pro
Key features include:
Semax is commonly studied in research involving:
It remains a valuable research tool for investigating mechanisms involved in neuronal communication and cognitive performance.
This material is intended for laboratory research use only and is not approved for human or veterinary applications.